Cargando…
Docking study of novel antihyperlipidemic thieno[2,3-d]pyrimidine; LM-1554, with some molecular targets related to hyperlipidemia - an investigation into its mechanism of action
An investigation into the mechanism of antihyperlipidemic action of 2-chloromethyl-5,6,7,8-tetrahydrobenzo(b)thieno[2,3-d]pyrimidin-4(3H)-one (LM-1554) was carried out through docking experiments with six different molecular targets; Niemann Pick C1 Like1 protein (NPC1L1), ATP citrate lyase (ACL), C...
Autores principales: | Khedkar, Vijay M, Arya, Nikhilesh, Coutinho, Evans C, Shishoo, Chamanlal J, Jain, Kishor S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221561/ https://www.ncbi.nlm.nih.gov/pubmed/25392798 http://dx.doi.org/10.1186/2193-1801-3-628 |
Ejemplares similares
-
Pharmacokinetic Study of a Novel Antihyperlipidemic Agent LM-13765- A Prodrug
por: Shah, T. M., et al.
Publicado: (2009) -
Synthesis, Characterization and Biological Studies of Some Novel Thieno[2,3-d]pyrimidines
por: Al-Taisan, Khulud M., et al.
Publicado: (2010) -
Design, synthesis, docking, MD simulations, and anti-proliferative evaluation of thieno[2,3-d]pyrimidine derivatives as new EGFR inhibitors
por: Sobh, Eman A., et al.
Publicado: (2023) -
Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-d]pyrimidines targeting VEGFR-2
por: El-Metwally, Souad A., et al.
Publicado: (2023) -
A Simple Synthesis of Some New Thienopyridine and Thieno-pyrimidine Derivatives
por: El-Saghier, Ahmed M. M.
Publicado: (2002)